Literature DB >> 2346917

Relationship of severe dysplasia to stage B adenocarcinoma of the prostate.

B D Quinn1, K R Cho, J I Epstein.   

Abstract

Severe dysplasia was studied in totally embedded radical prostatectomy specimens from 40 Stage B, intermediate-grade prostate cancers. All 40 cases had severe dysplasia which varied in amount (extensive in 35% of cases; intermediate in 55%; minimal in 10%). Severe dysplasia was predominantly concentrated in peripheral and posterior regions of the gland. Those cases with extensive severe dysplasia had more multifocal small cancers (14.6/case) compared with cases with intermediate (7.5/case) or minimal severe dysplasia (5.5/case). Most dominant tumor nodules had some intermingled severe dysplasia, and in 30% of the dominant tumor nodules, intermingled severe dysplasia occupied between 10% and 25% of the tumor nodule. Severe dysplasia was located next to the dominant tumor nodule in all cases. Nineteen percent of dominant tumor nodules had extensive adjacent severe dysplasia ranging from 5 to 14 mm in maximum diameter, showing that the potential exists for needle biopsy of prostate cancers to obtain only severe dysplasia. These data show a close relationship between severe dysplasia and Stage B cancers. In contrast, centrally located low-grade multifocal cancers, as seen in Stage A (incidental) carcinoma, had a significantly weaker association with severe dysplasia as compared with central, intermediate-grade, multifocal tumors or peripheral multifocal tumors of any grade.

Entities:  

Mesh:

Year:  1990        PMID: 2346917     DOI: 10.1002/1097-0142(19900515)65:10<2328::aid-cncr2820651027>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

Review 1.  Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance.

Authors:  R Montironi; R Mazzucchelli; F Algaba; A Lopez-Beltran
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

2.  Bax-interacting factor-1 expression in prostate cancer.

Authors:  Domenico Coppola; Cecilia Oliveri; Zena Sayegh; David Boulware; Yoshinori Takahashi; Julio Pow-Sang; Julie Y Djeu; Hong-Gang Wang
Journal:  Clin Genitourin Cancer       Date:  2008-09       Impact factor: 2.872

3.  High-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer.

Authors:  Debra L Zynger; Ximing Yang
Journal:  Int J Clin Exp Pathol       Date:  2008-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.